Plus Therapeutics Inc

NASDAQ:PSTV   10:52:02 AM EDT
1.91
-0.04 (-2.05%)
Earnings Announcements

Plus Therapeutics Reports Q2 Loss Per Share $0.25

Published: 07/22/2021 20:31 GMT
Plus Therapeutics Inc (PSTV) - Plus Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights.
Q2 Loss per Share $0.25.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.24

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.